Drug Prices
Get the facts on 8 common misconceptions about the rising costs of prescription drugs.
The AHA joined by the Association of American Medical Colleges and America’s Essential Hospitals today will urge a federal court to prevent the Department of Health and Human Services from reducing Medicare payments under the 340B drug savings program by nearly 30% effective Jan. 1.
For 25 years, the 340B drug savings program, at no cost to the government, has enabled eligible hospitals to purchase certain outpatient drugs from pharmaceutical manufacturers at discounted prices. This allows the participating hospitals to use the savings from the discounts to provide an expanded…
A bipartisan group of six senators yesterday urged Senate leadership to include in a year-end package, legislation that would prevent a dramatic reduction in Medicare Part B payments for certain hospitals that participate in the 340B drug savings program. The Centers for Medicare & Medicaid…
U.S. District Court Judge Rudolph Contreras will hear arguments Dec.
Press Release
Hospital Groups File Lawsuit to Stop Significant Payment Cuts for 340B Hospitals
Today, the American Hospital Association (AHA), the Association of American Medical Colleges (AAMC) and America’s Essential Hospitals filed a lawsuit against the U.S. Department of Health and Human…
Hospitals bear a heavy financial burden when the cost of drugs increases. They are not only major purchasers of drugs, but patients often end up in the hospital when they cannot afford to take their medications as prescribed. To that end, the American Hospital Association is proud to be a member of…
Millions of Americans worry about the high costs of life-saving prescription drugs. That’s why 25 years ago, Congress created the 340B Drug Pricing Program to help hospitals expand access to prescription drugs and support essential services for our most vulnerable patients.
The program constitutes…
Fact: Drug spending is significant and growing each year. Drug manufacturers like to point to retail drug spending, which is around 10 percent of total health care spending,i while ignoring total drug spending, which was 16.7 percent (or $457 billion) in 2015
The Pharmaceutical Research and Manufacturers of America (PhRMA) released yet another report designed to obfuscate the issue of sky-rocketing drug prices. Once again, PhRMA turned its sights on hospitals in just another example of PhRMA choosing to blame others rather than looking inward at the…